BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Hisamitsu Pharmaceutical Co., Inc. 

Chiyoda-ku, Marunouchi 1-11-1

Tokyo    100-6221  Japan
Phone: 81-0-3-5293-1720 Fax: 81-0-3-5293-1724


SEARCH JOBS

View Clinical Trials from BioPharm Insight



Industry
Pharmaceutical






 Company News
Menopause Drugs From Depomed, Inc. (DEPO), Hisamitsu Pharmaceutical Offer Benefits 3/1/2013 8:02:38 AM    More...
Hisamitsu Pharmaceutical Announces Two New FDA Approved Over-The-Counter Pain Relief Patches 5/24/2010 8:55:01 AM    More...
Hisamitsu Pharmaceutical Completes $428 Million Noven Pharmaceuticals Inc. (NOVN) Purchase 8/28/2009 7:13:21 AM    More...
Hisamitsu Pharmaceutical Announces Expiration of Subsequent Offering Period and Completion of Tender Offer for Outstanding Shares of Noven Pharmaceuticals Inc. (NOVN) 8/27/2009 10:14:39 AM    More...
Hisamitsu Pharmaceutical Announces Expiration of Initial Tender Offer Period for Outstanding Shares of Noven Pharmaceuticals Inc. (NOVN) and Commencement of Subsequent Offering Period 8/20/2009 8:44:08 AM    More...
Hisamitsu Pharmaceutical Announces Expiration of HSR Waiting Period for Its Proposed Acquisition of Noven Pharmaceuticals Inc. (NOVN) 8/13/2009 12:19:27 PM    More...
Hisamitsu Pharmaceutical Begins Tender Offer for All Outstanding Shares of Noven Pharmaceuticals Inc. (NOVN) 7/23/2009 9:06:55 AM    More...
Japan's Hisamitsu Pharmaceutical to Buy Noven Pharmaceuticals Inc. (NOVN) for $430 Million, To Expand U.S. Presence 7/14/2009 7:03:39 AM    More...
Hisamitsu Pharmaceutical , Nippon Shinyaku Co., Ltd. Conclude Joint Development Agreement For HFT-290 Cancer Pain Palliative Care Agent 10/19/2005 5:13:14 PM    More...
SS Pharmaceutical Co. Ltd. To Transfer Ethical Drug Business To Hisamitsu Pharmaceutical In April 2005 10/19/2005 5:11:30 PM    More...